Back to School Shopping with a Cause

I get tired of the same seven colors of folders and notebooks. By the time I have bought all three of my girls back to school notebooks, I am so tired of flowers, Miley Cyrus and primary colors I could scream. That’s part of why I love Carolina Pad – they have always offered great customer service and awesome designs, but now I’m even a bigger fan than before.

When Jacqueline Savage McFee (www.jackiemcfee.com), signature designer for Carolina Pad (www.carolinapad.com) – the industry leader in trendy school, office and organizational fashion products, got the devastating news that her two-year-old cousin, Kendall Sierens, was diagnosed with leukemia, it brought things into perspective for her. It also created a spark. The Kendall Kollection – a collection of colorful high-end school supplies inspired by the artist’s young cousin – was born in 2008 and has been raising funds and awareness for The Leukemia & Lymphoma Society. The partnership between Jackie McFee, Carolina Pad and The Leukemia & Lymphoma Society continues for 2009 with fresh new designs. This wildly successful collection is available at major national retailers including Wal-Mart, K-Mart and Office Max, as well as grocery and drug store chains.

Kendall is now almost six-years old and in remission, but the battle continues for thousands of other children just like her. We look forward to another year of helping The Leukemia & Lymphoma Society in its effort to find cures and better therapies for patients with leukemia, lymphoma and myeloma.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap